Literature DB >> 2947748

Alterations in the coronary circulation in hypertrophied ventricles.

M L Marcus, D G Harrison, W M Chilian, S Koyanagi, T Inou, R J Tomanek, J B Martins, C L Eastham, L F Hiratzka.   

Abstract

During the past decade our understanding of the complex interaction between cardiac muscle and coronary vascular growth has increased substantially. Some types of cardiac hypertrophy, for example, left ventricular hypertrophy secondary to hyperthyroidism, are associated with increased coronary vascular growth. However, in most animal preparations of hypertrophy and in several clinical types of hypertrophy of the left and/or right ventricles, pathologic cardiac enlargement impairs the ability of the coronary circulation to allow normal increases and perfusion in response to intense dilator stimuli. In general, clinical studies have demonstrated far more profound abnormalities than studies in experimental animals. These observations provide a plausible explanation of why patients with hypertrophied ventricles often exhibit signs and symptoms of myocardial ischemia in the absence of coronary obstructive disease. The recent observation that experimentally produced left ventricular hypertrophy secondary to renal hypertension augments infarct size and the incidence of sudden lethal arrhythmias has additional implications relevant to the interaction between cardiac hypertrophy and myocardial perfusion. Although coronary reserve is impaired in many types of pathologic hypertrophy, the anatomic or biochemical basis for these observations remains elusive.

Entities:  

Mesh:

Year:  1987        PMID: 2947748

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  36 in total

Review 1.  Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

Authors:  D J Sheridan; M P Kingsbury; N A Flores
Journal:  Br J Clin Pharmacol       Date:  1999-02       Impact factor: 4.335

2.  [Arterial hypertension in patients with coronary artery disease].

Authors:  T Graf; H Schunkert
Journal:  Herz       Date:  2012-03       Impact factor: 1.443

3.  Myocardial blood volume reserve by intravenous contrast echocardiography predicts improvement in left ventricular function in patients with nonischemic dilated cardiomyopathy.

Authors:  Yoko Miyata-Fukuoka; Hiroya Kawai; Osamu Iseki; Yoshio Yamanaka; Yoshiaki Ueda; Mitsuhiro Yokoyama; Ken-Ichi Hirata
Journal:  J Echocardiogr       Date:  2016-07-09

4.  Coronary flow reserve in hypertrophic cardiomyopathy: relation with microvascular dysfunction and pathophysiological characteristics.

Authors:  M J Kofflard; M Michels; R Krams; M Kliffen; M L Geleijnse; F J Ten Cate; P W Serruys
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

5.  Doppler estimation of reduced coronary flow reserve in mice with pressure overload cardiac hypertrophy.

Authors:  Craig J Hartley; Anilkumar K Reddy; Sridhar Madala; Lloyd H Michael; Mark L Entman; George E Taffet
Journal:  Ultrasound Med Biol       Date:  2008-02-06       Impact factor: 2.998

Review 6.  Regulation of myocardial oxygen delivery.

Authors:  B Schremmer; J F Dhainaut
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

7.  State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association.

Authors:  Michael Simons; Kari Alitalo; Brian H Annex; Hellmut G Augustin; Craig Beam; Bradford C Berk; Tatiana Byzova; Peter Carmeliet; William Chilian; John P Cooke; George E Davis; Anne Eichmann; M Luisa Iruela-Arispe; Eli Keshet; Albert J Sinusas; Christiana Ruhrberg; Y Joseph Woo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-04-30       Impact factor: 17.367

8.  Vascular endothelial growth factor delays onset of failure in pressure-overload hypertrophy through matrix metalloproteinase activation and angiogenesis.

Authors:  I Friehs; R E Margossian; A M Moran; H Cao-Danh; M A Moses; P J del Nido
Journal:  Basic Res Cardiol       Date:  2005-12-23       Impact factor: 17.165

Review 9.  Microvascular coronary dysfunction in women: pathophysiology, diagnosis, and management.

Authors:  Kamlesh Kothawade; C Noel Bairey Merz
Journal:  Curr Probl Cardiol       Date:  2011-08       Impact factor: 5.200

10.  A case of critical aortic stenosis masquerading as acute coronary syndrome.

Authors:  Siddharth A Wayangankar; Tarun W Dasari; Pedro M Lozano; Karen J Beckman
Journal:  Cardiol Res Pract       Date:  2010-07-20       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.